BioSpace News Archive

ChromaDex Corp. (NASDAQ: CDXC) today announced that it has appointed two new members to its Board of Directors: Kristin Patrick, Executive Vice President and Chief Marketing Officer of Claire’s Inc., and Ann Cohen, Executive Vice President and Chief Financial Officer of The Institute of Internal Auditors (The IIA).

PLx Pharma Inc. today announced that it will release its 2022 first quarter financial results before the opening of the U.S. financial markets on Friday, May 13, 2022.

BD (Becton, Dickinson and Company) today announced the formation of the Sustainable Medical Technology Institute.

CareDx, Inc. today announced the presentation of new data during the Tandem Meetings, Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR being held on April 23-26.

Tivity Health, Inc. today announced that its financial results for the first quarter ending March 31, 2022 , will be released after market close on Thursday, May 5, 2022.

Lantern Pharma Inc. today announced that it will report its first quarter 2022 financial results on Tuesday, May 3, 2022, after the financial markets close.

Novavax, Inc. has initiated administration of the first booster doses of NVX-CoV2373.

Bruker Launches Unique LiquidArray ® Multiplex PCR Assays.

CureVac N.V. will report financial results, and provide business updates for the fourth quarter and full-year 2021 on Thursday, April 28, 2022.

Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), today announced the start of data analysis of the multi-center, global Phase III AGENT Study investigating arfolitixorin in combination with 5-FU, oxaliplatin and bevacizumab in advanced, metastatic colorectal cancer (mCRC).